Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Business News
Eisai Co Ltd
Breaking News: Business
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Abbvie Inc
stocks
Pultegroup Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Uber Technologies Inc
Chipotle Mexican Grill Inc
Chevron Corp
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
Micron Technology Inc
Fox Corp/ Class A
GE Vernova Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
Investing
Tesla Inc
Norfolk Southern Corp
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Health care industry
Biogen Inc
Business
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
US: News
Earnings
Health & Science
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Breaking news
Companies
Business
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Pharmaceuticals
Health & Science
Novo Nordisk A/S
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Health care industry
Biogen Inc
Business
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Mad Money
Stock markets
U/S/ Markets
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Fidelis Insurance Holdings Ltd
Bank of America Corp
Micron Technology Inc
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Economy
General Motors Co
Investment strategy
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Companies
Health care industry
Biogen Inc
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Biogen Inc
Health & Science
Health care industry
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
US: News
Earnings
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Coinbase Global Inc
Verizon Communications Inc
PepsiCo Inc/
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Biogen Inc
Business
Health care industry
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Amgen Inc
Health & Science
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Business
Biogen Inc
Technology
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
US: News
Pharmaceuticals
Health & Science
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Dividends
Enphase Energy Inc
Business
From
CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
Finance
Alaska Air Group Inc
Packaging Corp of America
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Wells Fargo & Co
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Economy
Meta Platforms Inc
Bank of America Corp
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Eisai Co Ltd
Business News
Science
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
US: News
Social issues
Health & Science
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Health care industry
Business
Biogen Inc
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.